Difference between revisions of "Category:Malignant solid neoplasm, EGFR-mutated medications"
Jump to navigation
Jump to search
(Created page with "Medications with some degree of efficacy in the treatment of EGFR-mutated tumors, regardless of anatomic site of origin. Category:Site-agnostic medications") |
m (Jwarner moved page Category:Solid malignant neoplasm, EGFR-mutated medications to Category:Malignant solid neoplasm, EGFR-mutated medications) |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | Medications with some degree of efficacy in the treatment of EGFR-mutated tumors, regardless of anatomic site of origin. | + | Medications with some degree of efficacy in the treatment of [[EGFR|EGFR-mutated tumors]], regardless of anatomic site of origin. |
[[Category:Site-agnostic medications]] | [[Category:Site-agnostic medications]] | ||
Latest revision as of 16:26, 21 September 2023
Medications with some degree of efficacy in the treatment of EGFR-mutated tumors, regardless of anatomic site of origin.
Pages in category "Malignant solid neoplasm, EGFR-mutated medications"
This category contains only the following page.